A recent white paper by Amazon Web Services offers insights into how companies could benefit from bringing together the cloud and real-world evidence. Insights gathered from RWE, according to the white paper, stands to be a significant boon to the drug lifecycle and hasten innovation while […]
Latest Stories
The Kinetix Group’s John Strapp Talks Health Industry
John Strapp, Kinetix Group co-founder and chairman, recently sat with MM&M's Kara Giannecchini to discuss the current health care landscape. "If you think back, it was individual doctors in a fee-for-service world making decisions of products that they use," Strapp said during the interview. […]
Report: Insurers Found Solid Footing in Second Quarter
Health insurers managed to establish some stability in the second quarter this year despite a number of obstacles, including Republicans' push to quash the Affordable Care Act, according to a Healthcare Dive report. "2Q is a critical quarter for (managed care organizations) because it is the point […]
Mitchell: All of Us Will Offer ‘Largest, the Richest Biomedical Data Set Ever’
Edith Mitchell, Thomas Jefferson University professor of medicine and 116th president of the National Medical Association, says the All of Us Research program will be the "largest, the richest biomedical data set ever." Mitchell made the comments during her recent appearance on the Relentless […]
Dems Struggle to Unite on Drug Prices
While Democrats hold significantly more trust from constituents on health care matters, the party is struggling to form a cohesive one against high drug prices, STAT reports. "The Democrats do not have a concise drug plan," Harvard political scientist Robert Blendon tells STAT. "Most big plans that […]
AMCP Offering Corporate Training Program at Nexus
The Academy of Managed Care Pharmacy is offering a corporate training program at its upcoming Nexus 2018 meeting in Orlando. The training programs are set for noon - 5:15 p.m. Oct. 22 and 8 a.m. - 12:15 p.m. Oct. 23. According to an email, the program gives participants the opportunity to interact […]
Study: High ACA Rates Slowing Competition
A recent study published Monday in Health Affairs says less competition among insurers has led to higher health care premiums under the Affordable Care Act's insurance marketplaces, according to a Washington Examiner report. The study examined price hikes in 2017 and 2018 on the […]
Federal Agencies Partner to Combat Drug Monopolies, High Costs
The Food and Drug Administration and Federal Trade Commission are reportedly joining forces to take on high prescription drug prices, Bloomberg Law reports. Despite the two agencies having different overall missions, the partnership could apply more pressure on brand drugmakers and pharmacy benefit […]
Certara Software Backs 95% of 20 Novel Drug Approvals this Year, Acquires Analytica Laser
Certara says its drug development software supported 95 percent of the 20 novel drugs given the OK by the Food and Drug Administration in the first half of 2018, according to a Fierce Biotech report. The company added that the number shows in silico tools are playing an increasingly important role […]
Report: FDA Seeks More Examples of RWE Use
The U.S. Food and Drug Administration is continuing efforts on the front of real-world evidence. However, according to a Pink Sheet report, FDA Center for Drug Evaluation and Research Director Janet Woodcock says the use of real-world data is more likely to stay on a case-by-case basis. To read […]
